Transaera, Inc. | $10,500,000 | (Nov 5, 2024)
Algebrik AI | $4,000,000 | (Nov 5, 2024)
cloudsquid | $1,000,000 | (Nov 5, 2024)
Certified by Founder
Lodge
Arpeggio Biosciences
start up
United States
- Boulder, CO
- 08/09/2022
- Series A
- $17,000,000
Our technology combines a proprietary biological assay and machine learning algorithms that, together, enable rapid, high-resolution snapshots of cellular dynamics following drug treatment. These snapshots are then analyzed to reveal the biological networks that determine a drug’s function and guide therapeutic development.
We are comprised of a talented, diversely-skilled team, working together towards the mission of helping bring new therapies to patients with epigenetically-driven diseases.
- Industry Biotechnology Research
- Website https://www.arpeggiobio.com/
- LinkedIn https://www.linkedin.com/company/arpeggio-biosciences/
Related People
Joey AzofeifaFounder
United States -
Boulder, Colorado
I work with biologists, mathematicians and computer scientists to build technology that will better our understanding of human disease.
Cintoo | $40,246,701 | (Nov 5, 2024)
Further | $4,100,000 | (Nov 5, 2024)
Plato | $6,500,000 | (Nov 5, 2024)
Advex AI | $3,500,000 | (Nov 5, 2024)
Birl | $647,878 | (Nov 5, 2024)
Insider. | $500,000,000 | (Nov 5, 2024)
OpenOrigins | $4,500,000 | (Nov 1, 2024)
Persana AI | $2,300,000 | (Nov 1, 2024)
Definition Health | $7,412,756 | (Nov 1, 2024)